Premier Asset Management LLC Kodiak Sciences Inc. Transaction History

Premier Asset Management LLC

  • $0
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$110.45 - $164.47 $541,867 - $806,889
-4,906 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$60.78 - $154.03 $75,427 - $191,151
1,241 Added 33.86%
4,906 $721,000
Q3 2020

Nov 16, 2020
BUY
$45.05 - $59.27 $165,108 - $217,224
3,665 New
3,665 $217,000

Others Institutions Holding KOD

# of Institutions
101
Shares Held
38.8M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $289M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Premier Asset Management LLC Portfolio

Follow Premier Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Premier Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email